Systemic Vasculitis

• CLINICAL_TRIALS trial_result · 2026-04-14
  Clinical Trial Update: Cardiovascular Status of Children 5 Years After Kawasaki Disease

  This completed trial update describes long-term cardiovascular outcomes in children five years after Kawasaki disease.

• CLINICAL_TRIALS research · 2025-06-25
  Clinical Trial Update: Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders

  This clinical trial investigates monitoring of circulating B-cells, rituximab levels, and anti-drug antibodies in patients with autoimmune c…

• CLINICAL_TRIALS research · 2025-02-04
  Clinical Trial Update: Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis

  A clinical trial evaluating platelet aggregability in patients with Takayasu arteritis and systemic vasculitis; the study is currently activ…

• CLINICAL_TRIALS trial_result · 2025-01-10
  Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]

  Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic di…

• CLINICAL_TRIALS research · 2024-10-15
  Clinical Trial Update: Rare AutoImmune SElf-management Programme Development

  This document reports a clinical trial development for a Rare Autoimmune Self-management Programme, currently recruiting across several auto…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-01-17
  Clinical Trial Update: COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases [Phase 2, Phase 3]

  A Phase 2/Phase 3 clinical trial update evaluating a COVID-19 vaccine booster in immunocompromised individuals with rheumatic diseases.

• CLINICAL_TRIALS research · 2018-06-26
  Clinical Trial Update: Study of Refractory and/or Relapsing TAkayasu aRTeritis

  A clinical trial update regarding refractory and relapsing Takayasu arteritis; further status details are not provided.

• CLINICAL_TRIALS trial_result · 2017-06-27
  Clinical Trial Update: GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases [Phase 3]

  Phase 3 trial evaluating GnRH agonist for ovarian protection during cyclophosphamide therapy in rheumatic diseases was terminated; results w…

• CLINICAL_TRIALS trial_result · 2012-10-15
  Clinical Trial Update: Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort

  A completed prospective cohort study (Co-Env) evaluated how environmental factors influence disease activity in spondyloarthritis and associ…